Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.8 USD | -0.72% | -0.22% | -2.94% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
26/04 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
- Stock Market
- Equities
- ABT Stock
- Charts Abbott Laboratories
- Static Chart